Classifying Patients with Spatial Neglect by "Aiming" Versus "Where" Spatial Bias May Explain Differential Response to Bromocriptine Treatment (P03.261)

CONCLUSIONS: Classifying spatial neglect may be vital to interpreting rehabilitation outcomes and treatment studies. In this group study, larger than those performed previously, patients with "aiming" bias appeared to respond favorably to bromocriptine. However, "aiming" neglect patients may also have had milder neglect than those with "where" bias. Therefore, identifying "aiming" bias may also identify milder forms of neglect likely to respond to bromocriptine. Future studies with more bias-characterized patients are indicated.Disclosure: Dr. Chaudhari has nothing to disclose. Dr. Shah has nothing to disclose. Dr. Goedert has nothing to disclose. Dr. Adler has received personal compensation for activities with Allergan and Avanir as a speaker. Dr. Barrett has received personal compensation for activities with WebMD. Dr. Barrett has received research support from Kessler Foundation, National Institutes of Health, the Wallerstein Foundation for Geriatric Improvement, the Department of Education/NIDRR.

Source: Neurology - February 14, 2013 Category: Neurology Authors: Chaudhari, A., Shah, P., Goedert, K., Adler, U., Barrett, A. Tags: P03 Neural Repair Source Type: research